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).a b s t r a c t
p73 is a transcription factor belonging to the p53 tumour suppressor family. p73/ mice exhibit a range
of phenotypes including neurological, reproductive and inflammatory defects. Although the role of p73
in the control of genomic stability explains part of these phenotypes, a clear mechanism of how p73
participates in the inflammatory response is still elusive. Interleukin-1b (IL-1b) has a crucial role in
mediating the inflammatory response. Because of its high potency to induce inflammation, the activation
and secretion of IL-1b is tightly regulated by large protein complexes, named inflammasomes. Inflam-
masomes regulate activation of proinflammatory caspase-1, which in turn proteolytically processes its
substrates, including pro-IL-1b. Caspase-1 gene transcription is strongly activated by p53 protein family
members including p73. Here, we have addressed whether p73 might be directly involved in IL-1b
regulation and therefore in the control of the inflammatory response. Our results show that TAp73b
upregulates pro-IL-1b mRNA and processed IL-1b protein. In addition, analysis of breast and lung cancer
patient cohorts demonstrated that interaction between p73 and IL-1b predicts a negative survival
outcome in these human cancers.
© 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
p73 belongs to the p53 family of transcription factors (p53, p63
and p73), that share a high degree of structural homology, espe-
cially in their DNA-binding domains [1]. The TP73 gene generates
multiple protein isoforms, which arise as a result of alternative
promoter usage and differential mRNA splicing at the 3'end. The
use of the second promoter generates DNp73 isoforms that lack the
transactivation (TA) domain present in the N terminus of the full
length p73 protein (TAp73), and alternative splicing gives rise to 7
isoforms (a e h) with different C-terminal sequences that vary in
specificity and activity [2,3]. The p53 family is considered among
the most powerful family of genes, having a significant impact on
several biological processes [4,5] ranging from cell cycle regulation
[6]/apoptosis [7,8], genome stability [8] and metabolism [9e11] to
organ development/homeostasis [12,13] and fertility [4,14]. p73r Inc. This is an open access articleitself has been implicated in many of these processes, including the
control of genome stability which is associated with its capacity to
exert tumour suppression and act as a reproduction censor
[4,15e18]. However, the original p73-deficient mouse, lacking all
p73 isoforms, shows no increased susceptibility to spontaneous
tumours, but a rather diffuse inflammation and infection, associ-
ated with severe rhinitis and purulent otitis media with massive
neutrophil infiltration. Despite these indications of inflammation
and infection, no obvious deficiencies in lymphoid or granulocyte
populations were detected in p73/ mice [1]. A recent analysis of
p73 null phenotypes identified a potential unifying mechanism for
these diverse phenotypes [19,20]. Marshall et al. showed that p73 is
required for the formation of multiciliated epithelia, and p73 binds
in close proximity to more than 100 cilia-associated genes that are
required for the development and maintenance of multiciliated
cells. Loss of ciliary biogenesis provides a unifying mechanism for
many phenotypes observed in p73/ including hydrocephalus;
hippocampal dysgenesis; sterility; and chronic inflammation/
infection of the lung, middle ear, and sinus [19,20].under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
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susceptibility to spontaneous and carcinogen-induced tumours
[16,21]. They also display higher circulating levels of proin-
flammatory cytokines in response to LPS treatment suggesting that
TAp73 has a role in macrophage polarization and innate immunity
[22]. These data suggest the possibility of a causative correlation
between the cancer phenotype and chronic inflammation for the
establishment of a tumorigenic context [22]. A function for p73 in
regulating inflammation is also suggested by several reports that
link p73 expression to inflammatory diseases such as gastritis and
otitis media [23,24]. However the mechanism and the molecular
basis behind these inflammatory effects remain largely unclear.
Inflammasomes are multiprotein complexes containing a
member of the NOD-like receptor (NLR) family, such as NLRP3 and
IPAF that act as important effectors of the innate immune system.
The NLR protein recruits the inflammasome-adaptor protein ASC,
which in turn interacts with caspase-1 leading to its activation.
Once activated, caspase-1, also known as interleukin-1b converting
enzyme, promotes the maturation of the proinflammatory cyto-
kines interleukin (IL)-1b and IL-18 and cause pyroptosis, a type of
inflammatory cell death [6,25e27]. However, unlike IL-18 which is
constitutively expressed, activation of IL-1b requires concomitant
transcriptional activation of the unprocessed IL-1b (pro IL-1b) gene;
this is mainlymediated by nuclear factor-kb (NF-kb) [28]. Processed
IL-1b, generated upon caspase-1 activation, provides positive feed-
forward stimulation for inflammatory cytokines, thereby ampli-
fying inflammation. Inflammasomes have been linked to a variety
of autoinflammatory and autoimmune diseases, including neuro-
degenerative disease, metabolic disorders and cancer [27,29].
Previous reports have described human caspase-1 as a direct
target of all p53-family proteins [30e32]. It has been shown that
p73a and p73b isoforms exert a substantial positive transcriptional
activation on the Caspase-1 promoter, leading to a significant
upregulation of caspase-1 expression upon TAp73 activation. Based
on this and older evidence we wanted to investigate whether p73
plays a direct role in the regulation of IL-1b. This regulation might
reflect an influence of TAp73 on inflammasomes and might in turn
have important implications for tumour inflammation.2. Materials and methods
2.1. Cell culture
The human non-small cell lung carcinoma cell line NCI-H1299
was maintained at 37 C in a CO2 incubator in RPMI medium,
containing L-glutamine, 4.5 g/L D-Glucose, 2.383 g/L HEPES Buffer,
1.5 g/L Sodium Bicarbonate, 110 mg/L Sodium Pyruvate (Gibco, Life
Technologies), supplemented with 10% FBS (Labtech) and with
Penicillin/Streptomycin (Gibco, Life Technologies).2.2. Cell transfection
For overexpression, H1299 cells were seeded 24 h before
transfection. Transfection was performed with 10 mg DNA (pcDNA
empty, pcDNA HA-TAp73a, pcDNA HA-TAp73b, pcDNA DN-TAp73a,
pcDNA HA-p53 wt, pcDNA HA-p53R273H) per 10 cm dish with
1.2  106 cells seeded using Lipofectamine 2000 Reagent (Invi-
trogen). Cells were collected 24 h after transfection.
For TAp73 knockdown in H1299 cells, 1.2  106 cells were
seeded per 10 cm dish 24 h before transfection. Transfection was
performed using 50 nM siRNA (control siRNA or siTAp73-1 and
siTAp73-2 (Ambion)) and Lipofectamine RNAiMAX (Invitrogen).
Each dish was split in two 24 h after transfection and cells were
collected 48 h after transfection.2.3. RNA extraction and quantitative real-time PCR
Total RNA was isolated from cells using the RNEasy Mini Kit
(Qiagen), according to the Qiagen company protocol. 2 mg of total
RNA was used to prepare cDNA using RevertAid H minus First
strand cDNA Synthesis kit (ThermoScientific), using Random
primers and the protocol from the kit. qPCRwas performed using 1/
10 of the prepared cDNA and Power SYBR Green PCR Master Mix
(Applied Biosystems). Relative gene expression was analyzed in
accordance with 7500 Software version 2.0.6 of Applied Bio-
systems. Gene expression levels were quantified according to the
comparative DDCt method and normalized to expression of the TBP
housekeeping gene. Sequences of the primers used for the qPCR
are: human TAp73 Fw CAGACAGCACCTACTTCGACCTT, Rev
CCGCCCACCACCTCATTA; p21 Fw CCTGTCACTGTCTTGTACCCT, Rev
GCGTTTGGAGTGGTAGAAATCT; p53 Fw CCCAAGCAATGGAT-
GATTTGA, Rev GGCATTCTGGGAGCTTCATCT; DNp73; Caspase-1 Fw
TGCCTGTTCCTGTGATGTGG, Rev TGTCCTGGGAAGAGGTAGAAA-
CATC; human IL-1b Fw TGCACCTGTACGATCACTGAAC, Rev
TTGCTCCATATCCTGTCCCTG; TBP Fw TCAAACCCA-
GAATTGTTCTCCTTAT, Rev CCTGAATCCCTTTAGAATAGGGTAGA.
2.4. Western blot analysis
For protein extraction, cells were lysed in RIPA buffer with
protease inhibitor cocktail tablets Complete, EDTA-free (Roche) and
phosphatase inhibitor cocktail tablets PhosSTOP (Roche). Lysates
were measured for protein concentration by using the Bio-Rad
Protein Assay (Bio-Rad), then mixed with Laemmli loading buffer,
electrophoresed on SDS-PAGE gels and separated proteins trans-
ferred to PVDF blotting membranes (Amersham, GE Healthcare).
Membranes were blocked for 1 h in 10% (m/vol) dry milk dissolved
in TBS with 1% (vol/vol) Tween-20 (TBSt); incubated with primary
antibodies overnight and with secondary antibodies conjugated
with horseradish peroxidase, for 1 h. Antibodies were diluted in
10% dry milk in TBSt: anti-HA 1:1000 (Covance), anti-GAPDH
1:40000 (Sigma), anti-p21 1:1000 (Santa Cruz Biotechnology),
anti-p73 1:3000 (Bethyl). To detect the signal ECLWestern Blotting
Detection Reagent (Amersham, GE Healthcare) or SuperSignalWest
Dura Chemiluminescent Substrate (Thermo Scientific) was used.
2.5. IL-1b enzyme-linked immunosorbent assay (ELISA)
P73 was overexpressed in H1299 cells as described above, and
cells were lysed 24 h after transfection in Non-denaturing lysis
buffer (20 mM Tris-HCl pH 8.0, 137 mM NaCl, 1% NP-40). Super-
natants were collected and concentrated 20 times using Amicon
Ultra-2mL Centrifugal filters Ultracel-10K (Merk Milipore). Super-
natants and cell lysates were collected and the level of IL-1b was
quantified using the Human IL-1b/IL-1F2 Quantikine ELISA kit (R&D
Systems) following the manufacturer's instructions. Quantification
was performed bymeasuring the absorbance at 450 nmwith 540 as
a reference using the InfiniteM200 PRO (TECAN)microplate reader.
2.6. Chromatin immunoprecipitation assay
TAp73b was overexpressed for 24 h. Cells were collected at 80%
confluency and fixed in 37% formaldehyde and subjected to soni-
cation for DNA shearing. Chromatin was sonicated and immuno-
precipitated with/without 10 mL anti-HA antibodies (Covance) or
10 mL nonspecific immunoglobulin G (IgG) antibodies (Invitrogen)
using the MAGnify ChIP System kit (Invitrogen). The co-
immunoprecipitated DNA fragments were amplified by qPCR. P21
and MDM2 were used as positive controls; L32 was used as nega-
tive control. The primers used were: IL-1b (RE in Exon1) Fw
Fig. 1. TAp73 overexpression increases expression of IL-1b in a non-small cell lung cancer cell line. HA-tagged p73 isoforms (TAp73a, TAp73b and DNp73) and HA-tagged p53 wt
and mutant p53R273H were overexpressed in the H1299 cell line for 24 h (A) mRNA level of IL-1b; (B) mRNA level of Caspase-1; (C) mRNA level of p21 were analyzed by qPCR.
Relative expression of genes was normalized against TBP and calculated as fold induction. The data shown are mean ± S.D. (n ¼ 4) *P < 0.05 (Student's T-test). (D) Protein levels of
HATAp73, p21, Caspase-1 and GAPDH were analyzed by WB. Figures show a representative replicate of 3 independent experiments.
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GAGACAG; IL-1b (RE in Intron5) Fw TCCTGGCAGCTTGCTAATTCTCC,
Rev GACTTGGGTGGACATGGTCCTG; MDM2 Fw GGTTGACT-
CAGCTTTTCCTCTTG, Rev GGAAAATGCATGGTTTAAATAGCC; p21 Fw
GGCTGGTGGCTATTTTGTCC, Rev CCCCTTCCTCACCTGAAAACA; L32
Fw TTCCTGGTCCACAACGTCAAG, Rev TGTGAGCGATCTCGGCAC.2.7. Bioinformatic analyses
Bioinformatic analysis was performed as previously described
[11]. Different cancer patient datasets (GSE31120; GSE3494;
GSE17537; GSE25136; and Van't Verr et al.) were used for the
analysis. The survival estimation analysis in p73/IL-1b positive and
negative groups was performed computing the correlation be-
tween p73 and IL-1b expression profiles. The samples were split in
two cohorts: “gene correlation” or “no correlation” in order to
group all samples with a maximal effect on correlation (maximal
increase in positive correlation) in the first cohort. The computation
was repeated until there would be no sample which could be
removed from cohort 1 to cohort 2 to increase the positive corre-
lation between p73 and IL-1b. The separation of patients into
“cohort 1” and “cohort 2” along with survival informationwas then
used to compute survival outcome. The R statistical package was
used to perform survival analyses and to draw KMplots.2.8. Statistics
Technical as well as biological triplicates of each experiment
were performed. Error bars indicate ±S.D. in each figure. Statistical
significance was determined using the unpaired two-tailed Stu-
dent's t-test using GraphPad Software. A p-value 0.05 was
considered statistically significant.3. Results
3.1. TAp73 induces expression of IL-1b
To evaluate the ability of different isoforms of p73 to regulate
the expression of interleukin-1b (IL-1b), we used the p53-null
human non-small cell lung carcinoma cell line NCI-H1299,
expressing endogenous TAp73. First, we overexpressed HA-
tagged p73 isoforms (TAp73a, TAp73b and DNp73) and HA-
tagged p53 wt and the p53R273H mutant for 24 h. To evaluate
whether p73 activation was associated with induced transcription
of the IL-1b gene, we performed real-time quantitative PCR. qPCR
showed a 3.5 fold increase of IL-1b mRNA level after TAp73b
overexpression, a 2 fold increase after p53 overexpression and a 1.5
fold increase after overexpression of TAp73a and DNp73 (Fig. 1a).
Protein and RNA levels of p73 isoforms (TAp73a, TAp73b and
DNp73) and HA-tagged p53 wt and p53R273H mutant were
Fig. 2. TAp73 regulates expression of IL-1b. (A) mRNA levels of IL-1b, Caspase-1, p21
and TAp73 were analyzed by qPCR after TAp73 knockdown in the H1299 cell line for
48 h. Relative expression of the genes was normalized against TBP and calculated as
fold induction. The data shown are mean ± S.D. (n ¼ 4). *P < 0.05 (Student's T-test). (B)
The protein level of p73 after 48 h of TAp73 knockdown was analyzed by WB.
Figures show a representative replicate of 3 independent experiments.
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gulation of transcriptional targets p21 and Caspase-1 confirmed p73
and p53 transcriptional activation (Fig. 1b, c, d).
To provide further evidence for p73-induced upregulation of IL-
1b we performed knockdown experiments in H1299 cells by
transfecting selective siRNAs for TAp73 isoforms. mRNA levels of IL-
1bwere downregulated after TAp73 silencing, as were the levels of
Caspase-1 and p21mRNA (Fig. 2a). Western blot analysis confirmed
TAp73 depletion (Fig. 2b).
Collectively these data demonstrate TAp73-dependent upregu-
lation of IL-1b expression at the RNA level both after TAp73 over-
expression and after TAp73 knockdown.3.2. IL-1b is not a direct target of TAp73
To investigate the possibility that TAp73 is able to directly bind a
responsive element (RE) in the promoter region, we performed
bioinformatics analysis to identify putative consensus p53RE ele-
ments in the promoter sequence of human IL-1b. We used Mat-
Inspector Professional software, which allows identification of p53-
like REs. Within the first 1300bp upstream and 1300bp down-
stream of transcription start site we identified one putative binding
site, which was located in Exon1 of the human IL-1b gene
between þ13 and þ38bp (Fig. 3a). Another putative RE for p53
family proteins was found trough the p53FamTaG database [33].
This RE was located in Intron5 of human IL-1b (Fig. 3b). To validate
the hypothesis of the direct regulation of IL-1b gene by p73 we
performed chromatin immunoprecipitation (ChIP) assays for the
two putative p53REs on the IL-1b gene after overexpression of the
TAp73b isoform. The results show that p73 does not bind to eitherconsensus RE (Fig. 3c,d). For positive controls, p21 and MDM2
promoters primers were used, with L32 primers as negative control
(Fig. 3e).
These results suggest that p73 promotes IL-1b expression not by
the direct interaction with the indicated REs of the IL-1b gene but
by another indirect mechanism.
3.3. TAp73b upregulates the mature IL-1b level
TAp73 strongly upregulates caspase-1. Hence, we reasoned that
TAp73 could regulate pro-IL1b processing rather than by direct
transactivation of the gene, thus increasing the level of mature IL-
1b. In order to investigate this, we performed the enzyme-linked
immunosorbent assay for the presence of IL-1b following over-
expression of p73 isoforms (TAp73a, TAp73b and DNp73) and HA-
tagged p53 wt and the p53R273H mutant for 24 h. ELISA assay
performed on the cell lysates showed increases in the level of IL-1b
in the sample after overexpression of the TAp73b isoform, with a
10 pg/mL concentration of IL-1b in this sample (Fig. 4a). However,
no detectable levels of IL-1b were observed in the supernatants,
even after 20 fold concentration, possibly indicating the inability of
the H1299 cells to secrete IL-1b. Therefore this result shows that
TAp73b can affect the maturation of IL-1b, but not the mechanism
of IL-1b secretion.
3.4. Correlation of TAp73 and IL-1b expression level predicts poor
patient prognosis
Cancer inflammation has been associated with poor patient
prognosis and therapy resistance. Consistently, high levels of IL-1b
have been shown to represent a negative prognostic marker. In
order to understand better the clinical relevance of p73-dependent
regulation of IL-1b, we evaluated the biological consequence of the
correlation between p73 and IL-1b. We used selected gene
expression datasets of human lung and breast cancers annotated
with patient survival information. Each group was split in two
different groups: the first included all the samples to maximize a
positive correlation between p73 and IL-1b, while in the second
cohort all the other samples were included. Thus, we clustered the
datasets into a group where the p73/IL-1b axis was present (gene
interaction) and a second in which it was absent (NO interaction).
The cohort with ‘gene interaction’ showed a significantly worse
survival outcome compared to the cohort ‘NO interaction’
(Fig. 4b,c). Thus, bioinformatics data provide evidence of poorer
survival in cancer patients with a positive correlation between p73
and IL-1b. Hence, these data highlight a potential role for a TAp73-
dependent regulation of the inflammasome, thus highlighting a
role for this axis in cancer pathogenesis.
4. Discussion
Our data demonstrate a relationship between TAp73 and IL-1b,
although this is not occurring through direct transcriptional con-
trol, suggesting that there might be additional participants in this
functional axis. TNFR/NF-kb and IL1R/NF-kb are major players
involved in transcriptional induction of pro-IL-1b. Under inflam-
matory conditions, activation of these cytokine-mediated pathways
promotes stabilization, nuclear translocation and activation of NF-
kb. Concomitantly, cytoplasmic caspase-1 is ready to promote
processing of pro-IL-1b to IL-1b. Upon TAp73 overexpression we
observed increased mRNA levels of pro-IL-1b as well as increased
levels of mature IL-1b. Thus, TAp73 exerts a dual action on IL-1b
activation (Fig. 4d). While the TAp73-dependent processing of pro-
IL-1b can be ascribed to direct transcriptional regulation of caspase-






































































































































































IL-1β (RE in Exon1) IL-1β (RE in Intron 5)
p21 MDM2 L32
Fig. 3. Chromatin immunoprecipitation assay. (A) Schematic image of IL-1b RE located in Exon1. (B) Schematic image of IL-1b RE located in Intron5. (C and D) Chromatin extracted
from H1299 with overexpressed HA-TAp73bwas incubated with anti-HA or IgG antibodies. (C) Immunoprecipitated DNAwas tested by qPCR for p53-Response element in Exon 1 of
IL-1b gene. (D) Immunoprecipitated DNA was tested by qPCR for p53-Response element in Intron 5 of IL-1b gene. (E) ChIP on p21 and MDM2 promoter was performed as positive
control and L32 was used as negative controls. Mouse IgG antibody was used as a negative control of the ChIP procedure. The data shown are mean ± S.D. (n ¼ 3).
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TAp73 [34], however it is unknownwhether TAp73might influence
NF-kb in the transcriptional regulation of pro-IL-1b. More studies
are needed to reveal the molecular mechanisms underlining our
observation.
Unlike most cytokines, IL-1b does not have a signal peptide and
therefore it is not secreted through the classical secretory pathway[35]. Secretion of IL-1b is a multistep process that requires both
upregulation of the precursor pro-IL-1b (31kD) and processing of
pro-IL-1b by caspase-1 to form its bioactive mature form (17kD).
Without this step, pro-IL-1b is polyubiquitinated and degraded by
the proteasome [36]. There are data showing that there is a fraction
of cellular IL-1b localised to the vesicles of an endolysosomal nature
that is targeted for degradation, but that can be redirected to the
Fig. 4. (A) TAp73b upregulates protein level of IL-1b in the H1299 cell lysates. HA-tagged p73 isoforms (TAp73a, TAp73b and DNp73) and HA-tagged p53 wt and p53R273H mutant
were overexpressed in H1299 cells for 24 h. Lysates were then harvested and analyzed for the presence of IL-1b using a cytokine-specific ELISA. The diagram displays the IL-1b
content (pg/mL) of cell lysates (intracellular IL-1b). The data shown are mean ± S.D. (n ¼ 3). (B and C) Panels represent patient survival estimation datasets of p73/IL-1b epositive
correlation groups compared with negative or absent correlation groups Patients with (B) breast cancer and (C) lung cancer. Patients were divided in two groups: group one e gene
interaction (positive correlation) and group two e no interaction (negative or absent correlation). (D) Schematic representation of the dual regulation exerted by TAp73 on IL-1b.
TAp73 overexpression promotes upregulation of IL-1b mRNA, however the transcriptional control does not appear to be mediated by a direct binding of TAp73 on IL-1b gene locus.
Additionally, TAp73 directly promotes expression of caspase-1, thus promoting processing of pro-IL-1b to IL-1b.
P. Vikhreva et al. / Biochemical and Biophysical Research Communications 482 (2017) 498e505 503extracellular space following an appropriate secretory stimulus.
However, the exact mechanism of secretion is poorly understood.Many observations probably exclude a single mechanism of
secretion, but suggest that there are multiple mechanisms [37].
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standard will detect, but considerably underestimate, the unpro-
cessed IL-1b precursor form present in the sample [38,39]. The
complexity of the secretion process might explain the intracellular
accumulation of IL-1b we observed in our lung cancer cell line
model. Additional stimuli might be required in H1299 to secrete
matured IL-1b. The use of an in vitro cell line indeed does not
appropriately recapitulate the conditions inwhich lung cancer cells
might produce and secrete IL-1b in the tumour microenvironment.
In fact, IL-1b is produced by many cell types, although the majority
of studies focus on its production by cells of the innate immune
system, such as monocytes and macrophages. The present study
raises the question about the regulation of IL-1b in non-immune
cells, although it still leaves open the possibility that TAp73 trig-
gers the upregulation and secretion of IL-1b in monocyte-
macrophage cell lines, such as the human THP.1 cells.
p73 plays a role in various cellular signalling pathways during
development and growth control, and the TA isoform has tumour
suppressor properties. Several isoforms of p73 exist with consid-
erable differences in their function.Whereas the functions of the N-
terminal isoforms (TA and DNp73) and their opposing pro- and
antiapoptotic roles have become evident, the functional differences
of the distinct C-terminal splice forms of TAp73 are not so clear.
Interestingly, our data show that overexpression of TAp73b isoform
leads to greater upregulation of IL-1bmRNA, and is the only isoform
that upregulates intracellular level of IL-1b.
IL-1b has found to be elevated in various types of cancers, and it
is known that IL-1b producing tumours have a bad prognosis
[40,41]. Our data are in agreement with these observations and
expand the prognostic value to the correlation between TAp73 and
IL-1b. This suggests that IL-1b could be a potential biomarker of
cancer prognosis. Because IL-1b can have both beneficial and
harmful effects, it especially important to know how this cytokine
is activated. There are contradicting data showing on one hand that
excessive inflammasome activation could possibly drive tumori-
genesis and on the other hand data that shows that the loss of
inflammasome activation could also increase cancer progression
[42e44]. Caspase-1 mRNA is strongly upregulated and it is known
to be controlled by p73 directly. More studies need to be done to
determine the mechanism of p73 influence on inflammasomes.
This report provides evidence that p73 and particularly the TAp73b
isoform affects IL-1b at both mRNA and maturation. Together with
the previous data that shows the direct regulation of caspase-1 by
p73 we hypothesise that there is a regulation of inflammasomes by
p73.
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